Podcast: Regulus Therapeutics and Outsourcing Strategies - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and Outsourcing Strategies


blog comments powered by Disqus


Focusing on outsourcing strategies, BioPharm International interviews for a second time Bal Bhat, senior director and head of chemistry at Regulus, a company that develops and manufactures oligonucleotides to support the discovery and development of microRNA therapeutics. Bhat discusses the reasoning behind Regulus’ choice of outsourcing partners and how working closely with those partners to harmonize methodology and data quality is crucial. Bhat also describes how engaging outsourcing partners with the excitement of microRNA technology enabled an improved working relationship with shared goals. Posted Nov. 2011.

Related article on Perspectives in MicroRNA Therapeutics

Podcast: Dr. Bhat focuses on microRNA Drug Delivery

ADVERTISEMENT

ADVERTISEMENT

PDA Announces Technical Report on Drug Shortages
September 9, 2014
European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
DPT Laboratories Acquires Media Pharmaceuticals' Lakewood Facilities
September 5, 2014
Merck KGaA Breaks Ground on Facility in China
September 5, 2014
FDA Releases Guidance Electronic Submission of Lot Distribution Reports
September 5, 2014
Author Guidelines

Click here